North American (United States and Canada) comparative susceptibility of two fluoroquinolones: ofloxacin and ciprofloxacin: A 53-medical-center sample of spectra of activity
- 31 January 1994
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 18 (1) , 49-56
- https://doi.org/10.1016/0732-8893(94)90133-3
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The north american component (the united states and canada) of an international comparative MIC trial monitoring ofloxacin resistanceDiagnostic Microbiology and Infectious Disease, 1993
- Ofloxacin, a new broad-spectrum fluoroquinolone results from a multicenter, national comparative activity surveillance studyDiagnostic Microbiology and Infectious Disease, 1992
- Fluoroquinolone (Lomefloxacin) International Surveillance Trial: A report of 30 months of monitoring in vitro activityThe American Journal of Medicine, 1992
- Fluoroquinolone resistance an evolving national problem or just a problem for some physicians?Diagnostic Microbiology and Infectious Disease, 1992
- OfloxacinInternational Journal of Antimicrobial Agents, 1991
- Activity of new quinolones against ciprofloxacin-resistant staphylococciAntimicrobial Agents and Chemotherapy, 1991
- Rapid Development of Ciprofloxacin Resistance in Methicillin-Susceptible and -Resistant Staphylococcus aureusThe Journal of Infectious Diseases, 1991
- Multicenter randomized study of single-dose ofloxacin versus amoxicillin-probenecid for treatment of uncomplicated gonococcal infectionAntimicrobial Agents and Chemotherapy, 1989
- CiprofloxacinDrugs, 1988
- OfloxacinDrugs, 1987